30 results
8-K
EX-10.1
EDSA
Edesa Biotech Inc
27 Jun 23
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role
4:45pm
, illegality, conflict of interest, gross incompetence or breach of any material obligation under this Agreement.
without cause, in which case
8-K
EX-10.1
guf7v8q1n58
3 Feb 21
Edesa Biotech Receives C$14 million for COVID-19 Study
8:00am
DEFA14A
fygb7o3k9mieopklp
24 Mar 20
Additional proxy soliciting materials
4:15pm
10-KT
EX-14.1
uzcyxw vcq
12 Dec 19
Annual report (with FYE transition)
4:55pm
8-K/A
EX-10.2
k76cgw5hkmxa 71uz
20 Jun 19
Departure of Directors or Certain Officers
4:01pm
8-K/A
EX-10.3
o9wrnalc7hc063y
20 Jun 19
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
1rouy6
10 Jun 19
Edesa Biotech and Stellar Biotechnologies Complete Business Combination
9:06am
DEFM14A
88ht5
18 Apr 19
Proxy related to merger
5:08pm
PREM14A
4cytzgm mj51ihnvwxnx
29 Mar 19
Preliminary proxy related to merger
4:18pm
424B4
ji4j2iy rb7vbbyqyqoe
14 May 18
Prospectus supplement with pricing info
12:00am
S-1/A
xohnqtw
8 May 18
IPO registration (amended)
12:00am